NuVasive reported GAAP net income of $19.201 million for the first three months of 2022, compared to a $7.51 million loss in the previous year. Revenue increased 8.4% to $265.973 million from $245.451 million a year earlier.
NuVasive reported GAAP net income of $19.201 million for the first three months of 2022, compared to a $7.51 million loss in the previous year. Revenue increased 8.4% to $265.973 million from $245.451 million a year earlier. 
ir.nuvasive.com
English (US) 